[1]
|
Roger V.L. (2013) Epidemiology of Heart Failure. Circulation Research, 113, 646-659.
https://doi.org/10.1161/CIRCRESAHA.113.300268
|
[2]
|
Störk, S., Handrock, R., Jacob, J., Walker, J., Calado, F., Lahoz, R., Hupfer, S. and Klebs, S. (2017) Epidemiology of Heart Failure in Germany: A Retrospective Database Study. Clinical Research in Cardiology, 106, 913-922.
https://doi.org/10.1007/s00392-017-1137-7
|
[3]
|
Chung, I., Goyal, D., Macfadyen, R.J. and Lip, G.Y. (2008) The Effects of Maximal Treadmill Graded Exercise Testing on Haemorheological, Haemodynamic and Flow Cytometry Platelet Markers in Patients with Systolic or Diastolic Heart Failure. European Journal of Clinical Investigation, 38, 150-158.
https://doi.org/10.1111/j.1365-2362.2008.01909.x
|
[4]
|
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey Jr., D.E., Drazner, M.H., et al. (2013) 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 128, e240-e327.
https://doi.org/10.1161/CIR.0b013e31829e8776
|
[5]
|
Lee, D.S., Gona, P., Vasan, R.S., Larson, M.G., Benjamin, E.J., Wang, T.J., Tu, J.V. and Levy, D. (2009) Relation of Disease Pathogenesis and Risk Factors to Heart Failure with Preserved or Reduced Ejection Fraction: Insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation, 119, 3070-3077.
https://doi.org/10.1161/CIRCULATIONAHA.108.815944
|
[6]
|
Andries, L.J., Kaluza, G., De Keulenaer, G.W., Mebazaa, A., Brutsaert, D.L. and Sys, S.U. (1996) Endocardial Endothelial Dysfunction and Heart Failure. Journal of Cardiac Failure, 2, S195-S202.
https://doi.org/10.1016/S1071-9164(96)80077-7
|
[7]
|
Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Sav-vatis, K., Escher, F., et al. (2011) Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients with Heart Failure and Normal Ejection Fraction. Circulation: Heart Failure, 4, 44-52. https://doi.org/10.1161/CIRCHEARTFAILURE.109.931451
|
[8]
|
Tsutsui, H., Isobe, M., Ito, H., Okumura, K., Ono, M., Kitakaze, M., et al. (2019) JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure-Digest Version. Circulation Journal, 83, 2084-2184.
https://doi.org/10.1253/circj.CJ-19-0342
|
[9]
|
Heidenreich, P.A., Albert, N.M., Allen, L.A., Bluemke, D.A., Butler, J., Fonarow, G.C., et al. (2013) Forecasting the Impact of Heart Failure in the United States: A Policy Statement from the American Heart Association. Circulation: Heart Failure, 6, 606-619. https://doi.org/10.1161/HHF.0b013e318291329a
|
[10]
|
Kim, D.H., Sabour, S., Sagar, U.N., Adams, S. and Whellan, D.J. (2008) Prevalence of Hypovitaminosis D in Cardiovascular Diseases (From the National Health and Nutri-tion Examination Survey 2001 to 2004). American Journal of Cardiology, 102, 1540-1544. https://doi.org/10.1016/j.amjcard.2008.06.067
|
[11]
|
Ameri, P., Ronco, D., Casu, M., Denegri, A., Bovio, M., Menoni, S., Ferone, D. and Murialdo G. (2010) High Prevalence of Vitamin D Deficiency and Its Association with Left Ventricular Dilation: An Echocardiography Study in Elderly Patients with Chronic Heart Failure. Nutrition, Metabolism & Cardiovascular Diseases, 20, 633-640.
https://doi.org/10.1016/j.numecd.2010.01.002
|
[12]
|
Gardner, D.G., Chen, S. and Glenn, D.J. (2013) Vitamin D and the Heart. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 305, R969-R977. https://doi.org/10.1152/ajpregu.00322.2013
|
[13]
|
Weishaar, R.E. and Simpson, R.U. (1987) Involvement of Vita-min D3 with Cardiovascular Function. II. Direct and Indirect Effects. American Journal of Physiology, 253, E675-E683. https://doi.org/10.1152/ajpendo.1987.253.6.E675
|
[14]
|
Chen, S., Law, C.S., Grigsby, C.L., Olsen, K., Hong, T.T., Zhang, Y., Yeghiazarians, Y. and Gardner, D.G. (2011) Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy. Circulation, 124, 1838- 1847. https://doi.org/10.1161/CIRCULATIONAHA.111.032680
|
[15]
|
Vaidya, A. and Williams, J.S. (2012) The Rela-tionship between Vitamin D and the Renin-Angiotensin System in the Pathophysiology of Hypertension, Kidney Disease, and Diabetes. Metabolism, 61, 450-458.
https://doi.org/10.1016/j.metabol.2011.09.007
|
[16]
|
Zhang, Y., Leung, D.Y., Richers, B.N., Liu, Y., Remigio, L.K., Riches, D.W. and Goleva, E. (2012) Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1. The Journal of Immunology, 188, 2127-2135. https://doi.org/10.4049/jimmunol.1102412
|
[17]
|
Caprio, M., Mammi, C. and Rosano, G.M. (2012) Vitamin D: A Novel Player in Endothelial Function and Dysfunction. Archives of Medical Science, 8, 4-5. https://doi.org/10.5114/aoms.2012.27271
|
[18]
|
Pilz, S., März, W., Wellnitz, B., Seelhorst, U., Fahrleitner‐Pammer, A., Dimai, H.P., Boehm, B.O. and Dobnig, H. (2008) Association of Vitamin D Deficiency with Heart Failure and Sud-den Cardiac Death in a Large Cross‐Sectional Study of Patients Referred for Coronary Angiography. The Journal of Clinical Endocrinology & Metabolism, 93, 3927-3935.
https://doi.org/10.1210/jc.2008-0784
|
[19]
|
Pilz, S., Tomaschitz, A., Drechsler, C., Dekker, J.M. and März, W. (2010) Vitamin D Deficiency and Myocardial Diseases. Molecular Nutrition & Food Research, 54, 1103-1113. https://doi.org/10.1002/mnfr.200900474
|
[20]
|
Schluter, K.D. and Piper, H.M. (1998) Left Ventricular Hypertrophy and Parathyroid Hormone: A Causal Connection? Cardiovascular Research, 39, 523-524. https://doi.org/10.1016/s0008-6363(98)00097-2
|
[21]
|
Haden, S.T., Brown, E.M., Hurwitz, S., Scott, J. and El-Hajj Fuleihan, G. (2000) The Effects of Age and Gender on Parathyroid Hormone Dynamics. Clinical Endocrinology, 52, 329-338.
https://doi.org/10.1046/j.1365-2265.2000.00912.x
|
[22]
|
DeBoer, R.A., Nayorm, M., de Filippi, C.R., Enserro, D., Bhambhani, V., Kizer, J.R., et al. (2018) Association of Cardiovascular Biomarkers with Incident Heart Failure with Preserved and Reduced Ejection Fraction. JAMA Cardiology, 3, 215-224. https://doi.org/10.1001/jamacardio.2017.4987
|
[23]
|
Jiang, P., Gao, Z., Zhao, W., Song, Y., Tang, X.-F., Xu, J.-J., Wang, H.-H., et al. (2019) Relationship between Fibrinogen Levels and Cardiovascular Events in Patients Receiving Percutaneous Coronary Intervention: A Large Single-Center Study. Chinese Medical Journal, 132, 914-921. https://doi.org/10.1097/CM9.0000000000000181
|
[24]
|
Mongirdiene, A., Kursvietiene, L. and Kasauskas, A. (2010) The Coagulation System Changes in Patients with Chronic Heart Failure. Medicina, 46, 642-647. https://doi.org/10.3390/medicina46090091
|
[25]
|
Witte, K.K., Ford, S.J., Preston, T., Parker, J.D. and Clark, A.L. (2008) Fibrinogen Synthesis Is Increased in Cachectic Patients with Chronic Heart Failure. International Journal of Car-diology, 129, 363-367.
https://doi.org/10.1016/j.ijcard.2007.07.119
|
[26]
|
Zhao, T.J., Yang, Q.K., Tan, C.Y., Bi, L.D., Li, J. and Miao, Z.L. (2020) Prognostic Value of D-Dimer/Fibrinogen Ratio in the Adverse Outcomes of Patients Hospitalized for Heart Fail-ure. Biomarkers in Medicine, 14, 1733-1745.
https://doi.org/10.2217/bmm-2020-0553
|
[27]
|
张洋, 于金星, 叶中倪, 李新强, 刘建茹, 王锡鸣, 李袁, 康金锁, 陈曦. MPV与冠心病心力衰竭患者预后的相关性研究[J]. 标记免疫分析与临床, 2016, 23(4): 360-363.
|
[28]
|
刘建华, 顾蓉, 乔建忠, 王涟, 徐标. 心力衰竭患者MPV的水平及其与BNP的相关性研究[J]. 现代生物医学进展, 2016, 16(16): 3058-3061+3093.
|
[29]
|
陆云燕, 魏文娟. 平均血小板体积与慢性心力衰竭的相关性[J]. 心脑血管病防治, 2019, 19(6): 531-533.
|
[30]
|
李艳秋, 陈广生, 马德渊, 贾仲瑞. 平均血小板体积与血小板计数比值对急性ST段抬高性心肌梗死患者行PCI预后的预测价值[J]. 中国急救医学, 2019, 39(5): 412-415.
|
[31]
|
Czerniuk, M.R., Bartoszewicz, Z., Dudzik-Niewiadomska, I., Pilecki, T., Górska, R. and Filipiak, K.J. (2019) Simple Platelet Markers: Mean Platelet Volume and Congestive Heart Failure Coexistent with Periodontal Disease. Pilot Studies. Cardiology Journal, 26, 253-259. https://doi.org/10.5603/CJ.a2017.0085
|
[32]
|
Moertl, D., Berger, R., Hammer, A., Hutuleac, R., Koppensteiner, R., Kopp, C.W., et al. (2011) Dose-Dependent Decrease of Platelet Activation and Tissue Factor by Omega-3 Polyunsaturated Fatty Acids in Patients with Advanced Chronic Heart Failure. Thrombosis and Haemostasis, 106, 457-465.
|
[33]
|
Pasic, J., Sullivan, M.D., Russo, J., Chandler, W.L. and Levy, W.C. (2004) Lack of Depression Ef-fect on Platelet Activation in Patients with Heart Failure. Psychiatry Research, 129, 289-292.
https://doi.org/10.1016/j.psychres.2004.09.008
|
[34]
|
Chung, I., Choudhury, A., Patel, J. and Lip, G.Y.H. (2008) Soluble CD40L, Platelet Surface CD40L and Total Platelet CD40L in Congestive Heart Failure: Relationship to Platelet Volume, Mass and Granularity. Journal of Internal Medicine, 263, 313-321. https://doi.org/10.1111/j.1365-2796.2007.01891.x
|
[35]
|
Chung, I., Choudhury, A. and Lip, G.Y. (2007) Platelet Activation in Acute, Decompensated Congestive Heart Failure. Thrombosis Research, 120, 709-713. https://doi.org/10.1016/j.thromres.2007.01.003
|
[36]
|
Kandis, H., Ozhan, H., Ordu, S., Erden, I., Caglar, O., Basar, C., et al. (2011) The Prognostic Value of Mean Platelet Volume in Decompensated Heart Failure. Emergency Medicine Journal, 28, 575-578.
https://doi.org/10.1136/emj.2009.088401
|